Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Real-World Experience With Pembrolizumab in Patients With Advanced Lung Cancer

Peng, Tzu Rong MS1; Wu, Ta Wei MS1,2

doi: 10.1097/MJT.0000000000000762
Letters to the Editor

1Department of Pharmacy, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan, Republic of China

2School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei City, Taiwan, Republic of China

The authors have no conflicts of interest to declare.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.